2024. Comparative clinical and laboratory evaluation of the effectiveness of a nanodispersed silica-based drug with antimicrobial properties for the local treatment of purulent inflammatory diseases of the maxillofacial area. Perioperaciina Medicina. 7, 1 (Sep. 2024), 25–31. DOI:https://doi.org/10.31636/prmd.v7i1.4.